JPMorgan Chase & Co. Increases Stake in Bristol-Myers Squibb Company

JPMorgan Chase & Co. has filed an amendment to its Schedule 13G, disclosing an increased ownership of 4.0% in Bristol-Myers Squibb Company. The filing, dated October 31, 2025, reveals that JPMorgan Chase & Co. now beneficially owns 81,890,781 shares of Bristol-Myers Squibb's common stock, a significant increase from its previous holdings. The shares are held through various subsidiaries, including J.P. Morgan Trust Company of Delaware, J.P. Morgan Securities LLC, and JPMorgan Chase Bank, National Association. The filing also certifies that the shares were acquired in the ordinary course of business and not for the purpose of influencing the control of the issuer.